Type I conventional dendritic cells relate to disease severity in virus‐induced asthma exacerbations. Issue 4 (3rd March 2022)
- Record Type:
- Journal Article
- Title:
- Type I conventional dendritic cells relate to disease severity in virus‐induced asthma exacerbations. Issue 4 (3rd March 2022)
- Main Title:
- Type I conventional dendritic cells relate to disease severity in virus‐induced asthma exacerbations
- Authors:
- Cameron, Aoife
Dhariwal, Jaideep
Upton, Nadine
Ranz Jimenez, Ismael
Paulsen, Malte
Wong, Ernie
Trujillo‐Torralbo, Maria‐Belen
del Rosario, Ajerico
Jackson, David J.
Edwards, Michael R.
Johnston, Sebastian L.
Walton, Ross P. - Abstract:
- Abstract: Rationale: Rhinoviruses are the major precipitant of asthma exacerbations and individuals with asthma experience more severe/prolonged rhinovirus infections. Concurrent viral infection and allergen exposure synergistically increase exacerbation risk. Although dendritic cells orchestrate immune responses to both virus and allergen, little is known about their role in viral asthma exacerbations. Objectives: To characterize dendritic cell populations present in the lower airways, and to assess whether their numbers are altered in asthma compared to healthy subjects prior to infection and during rhinovirus‐16 infection. Methods: Moderately‐severe atopic asthmatic patients and healthy controls were experimentally infected with rhinovirus‐16. Bronchoalveolar lavage was collected at baseline, day 3 and day 8 post infection and dendritic cells isolated using fluorescence activated cell sorting. Measurements and Main Results: Numbers of type I conventional dendritic cells, which cross prime CD8 + T helper cells and produce innate interferons, were significantly reduced in the lower airways of asthma patients compared to healthy controls at baseline. This reduction was associated serum IgE at baseline and with reduced numbers of CD8 + T helper cells and with increased viral replication, airway eosinophils and reduced lung function during infection. IgE receptor expression on lower airway plasmacytoid dendritic cells was significantly increased in asthma, consistent with aAbstract: Rationale: Rhinoviruses are the major precipitant of asthma exacerbations and individuals with asthma experience more severe/prolonged rhinovirus infections. Concurrent viral infection and allergen exposure synergistically increase exacerbation risk. Although dendritic cells orchestrate immune responses to both virus and allergen, little is known about their role in viral asthma exacerbations. Objectives: To characterize dendritic cell populations present in the lower airways, and to assess whether their numbers are altered in asthma compared to healthy subjects prior to infection and during rhinovirus‐16 infection. Methods: Moderately‐severe atopic asthmatic patients and healthy controls were experimentally infected with rhinovirus‐16. Bronchoalveolar lavage was collected at baseline, day 3 and day 8 post infection and dendritic cells isolated using fluorescence activated cell sorting. Measurements and Main Results: Numbers of type I conventional dendritic cells, which cross prime CD8 + T helper cells and produce innate interferons, were significantly reduced in the lower airways of asthma patients compared to healthy controls at baseline. This reduction was associated serum IgE at baseline and with reduced numbers of CD8 + T helper cells and with increased viral replication, airway eosinophils and reduced lung function during infection. IgE receptor expression on lower airway plasmacytoid dendritic cells was significantly increased in asthma, consistent with a reduced capacity to produce innate interferons. Conclusions: Reduced numbers of anti‐viral type I conventional dendritic cells in asthma are associated with adverse outcomes during rhinovirus infection. This, with increased FcεR1α expression on lower airway plasmacytoid DCs could mediate the more permissive respiratory viral infection observed in asthma patients. … (more)
- Is Part Of:
- Clinical & experimental allergy. Volume 52:Issue 4(2022)
- Journal:
- Clinical & experimental allergy
- Issue:
- Volume 52:Issue 4(2022)
- Issue Display:
- Volume 52, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 4
- Issue Sort Value:
- 2022-0052-0004-0000
- Page Start:
- 550
- Page End:
- 560
- Publication Date:
- 2022-03-03
- Subjects:
- atopy -- DC -- rhinovirus
Allergy -- Periodicals
Immunology -- Periodicals
616.97 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0954-7894&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2222 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cea.14116 ↗
- Languages:
- English
- ISSNs:
- 0954-7894
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.249700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26886.xml